1. Introduction
Knee osteoarthritis (KOA) is a global public health concern and one of the leading causes of physical impairment and disability worldwide [
1,
2]. As there are currently no single disease-modifying interventions for KOA [
3], conservative treatments such as pharmacological therapy and rehabilitation exercises have often been complemented with physical electro-modalities to optimize treatment outcomes [
4]. These include low-level (LLLT) [
5,
6] and high-intensity laser therapy (HILT) [
7,
8], therapeutic ultrasound, and transcutaneous electrical nerve stimulation [
9]. In recent years, photobiomodulation therapy, specifically LLLT and HILT have emerged as the most promising modalities [
4,
8,
10], as both can reduce pain and inflammation [
6,
7], augment tissue repair [
11,
12], increase blood circulation [
13], and improve physical function and performance [
6,
7]. Since previous trials had predominantly evaluated either LLLT or HILT without comparing them directly [
14,
15], it remains unclear which modality is more effective in treating KOA [
6,
8,
16].
Photobiomodulation therapy is a non-invasive electro-modality that utilizes therapeutic doses of light to target injured or dysfunctional tissue, activating photo-biological mechanisms for pain relief and tissue healing [
11,
12]. It is theorized that the laser energy (photons) is absorbed by the tissue and cells, initiating cellular mitochondrial oxidative reactions that yield adenosine triphosphate (essential for optimal cell metabolism and healing), modulate low-level reactive oxygen species, and release nitric oxide as a potent vasodilator to reduce pain and inflammation [
11,
12]. Low-level laser therapy (< 500 mW) was first investigated on KOA by Gur et al. (2003) [
17]. High-intensity laser therapy is an advanced form of laser therapy which delivers higher energy output (greater than 500 mW), deeper tissue penetration (up to 15 cm), and is capable of inducing superficial hyperthermia (photothermic effects) [
11,
18]. These enhance oxidative processes and increase ATP synthesis in less time than LLLT [
11,
18]. Additionally, HILT with wavelengths over 1064 nm, has been demonstrated to target nerve endings directly, providing immediate pain relief [
8,
11]. Due to its greater anti-inflammatory, bio-stimulation, and photothermic advantages, HILT is considered more promising than LLLT for the treatment of KOA [
4,
11,
16]. Moreover, single-treatment clinical trials (indirect comparison) and meta-analysis suggest HILT is more effective than LLLT [
16]. However, a direct comparison between LLLT and HILT on KOA outcomes is lacking to support this supposition.
Kheshie et al. (2014) is one of the few studies to date that compared the effects of HILT and LLLT as an adjunct to KOA rehabilitation, concluding that HILT was more effective in improving KOA outcomes [
19]. Argumentatively, the study's small sample size, which only included male participants, and the reliance solely on patient-reported outcomes (VAS and WOMAC) limit the generalizability of its findings; considering the fact that KOA is more prevalent in females [
1]. Moreover, patient-reported outcome measures may be challenged due to potential subjective and biased interpretations [
20]. Thus, a randomized trial using robust research methods is warranted to distinguish the clinical effects of LLLT and HILT.
To sum up, current clinical evidence for comparing the effects of LLLT and HILT in treating KOA is limited due to methodological issues such as single-treatment clinical trials, single-sex participants, reliability and validity of outcome measures, and meta-analysis. As such, this study was designed to compare the clinical effects of LLLT and HILT as adjunctive treatment to rehabilitation exercise on pain, function, and disability levels in adults with mild to moderate KOA. The findings of this study could provide a valid justification for including laser therapies as a mainstream management option for KOA and enable health professionals to select the most efficient modality (LLLT or HILT) for optimal outcomes. It was hypothesized that HILT would provide better clinical outcomes than LLLT as an adjunctive treatment for KOA.
4. Discussion
This study compared the effects of LLLT and HILT as adjunctive treatment to rehabilitation exercise on pain, physical function and disability levels among patients with mild to moderate KOA. The respective laser and exercise interventions for both studied groups (LL+EX and HL+EX) were administered across 12 weekly sessions, and the study outcomes were evaluated at baseline and immediately post-intervention. Results showed that both groups exhibited statistically significant reductions in knee pain and disability scores, along with improved physical function and functional mobility compared to baseline; however, the HL+EX group had significantly higher mean differences of change by 50% for NPRS, 20% for KOOS, 6% for active knee flexion, and 3% for TUG relative to the LL+EX. Crucially, the changes in KOOS, NPRS, and active knee flexion scores in the HL+EX group exceeded the MCID threshold, suggesting a clinically relevant reduction in knee-related disability and pain, along with clinically significant improvements in physical function. Conversely, only the NPRS scores of the LL+EX group reached clinical significance. While no clinically significant changes were observed for functional mobility as measured by the TUG test in either laser group. This study's clinical evidence implies that combining HILT with usual KOA rehabilitation exercises leads to more substantial positive changes in clinical outcomes, specifically in pain, physical function, and knee-related disability, compared to LLLT.
This study acknowledged Kheshie et al. (2014) and Delkhosh et al. (2018) which evaluated the effect of HILT and LLLT as adjunctive treatment to KOA rehabilitation exercise. Kheshie et al. (2014) concluded that HL+EX was more effective than LL+EX in reducing pain and knee-related disability levels in patients with mild to moderate KOA [
19]. However, a few methodological issues may have confounded their findings. Kheshie et al. (2014) administered a homogenized dose of laser treatment to 1250 J per session; therefore, participants treatment times varied between LLLT (33 minutes) and HILT (15 minutes) [
19], which could potentially affect the treatment blindness. The study also employed a single-blinded design which could introduce assessor bias [
42]. Additionally, only male patients were recruited [
19]; thus, the results may not be generalizable to females, which has a higher representation [
1].
Meanwhile, Delkhosh et al. (2018) compared HL+EX and LL+EX effects on pain and knee-related disability in 45 female patients with KOA [
43]. The study relied on self-reported outcomes (VAS and WOMAC), similar to Kheshie et al. (2014). The results showed that both treatments had similar effects in reducing pain and knee-related disability measured by pain VAS and WOMAC, respectively [
43]. However, the study determined LLLT to be more appropriate due to its lower cost [
43]. The article was only available in English as an abstract, with the rest in Persian, making accurate details on the study's design, methodology (laser intervention), and results inaccessible. Nevertheless, information on the laser intervention was accessed based on the available trial protocol registration details. The study applied ten intervention sessions within two weeks, with five sessions per week [
43]. The LL+EX group received a laser output of 30 mW (830 nm of wavelength), while the HL+EX group received 3.2 W of power output (910 nm of wavelength) [
43]. Unfortunately, no information was available on important details such as treatment time, mode and location of laser application, energy density, or total energy delivered per session. Therefore, a comparison between the total laser dosage delivered based on the present study and Delkhosh et al. (2018) cannot be made. However, we believe that our laser treatment delivers higher total energy compared to the study by Delkhosh et al. (2018), as we are applying 12 sessions with power output ranging from 400 mW (LLLT) to 4 W (HILT), which may justify our significant findings regarding the difference between the two laser treatments. Hence, a double-blinded (participants and outcome assessors) study design involving patients with KOA of both sexes and the combination of self-reported, clinical, and performance-based outcomes assessment could provide more reliable and valid results [
23].
Based on recent studies, combining laser treatment with exercise, i.e. LL+EX [
6,
44] or HL+EX [
8,
15,
29] were more effective in reducing knee pain and stiffness, and enhancing physical function among patients with KOA than rehabilitation exercise alone. These improvements were attributed to the synergistic effects of laser technology and therapeutic exercise on tissue repair at the cellular level [
11,
12,
18]. Specifically, in this study, the higher reduction in knee pain scores in the HL+EX group compared to the LL+EX group can be attributed to the enhanced properties of high-power laser technology. These advantages include (i) a higher energy output and deeper tissue penetration than low-level laser therapy [
11,
18], (ii) an anti-inflammatory effect with pain modulation and impact on nerve endings for pain relief [
8,
11], and (iii) a scattering mode of laser radiation with therapeutic photo-thermal effects that induce localized muscle relaxation, reducing muscle spasms [
13,
18]. Additionally, on pain modulation and suppression of inflammation, HILT was found to induce the release of endorphins and serotonin at the peripheral nerve endings, decrease proinflammatory cytokines and other inflammatory mediators such as interleukin-1, interleukin-6, prostaglandin, C-reactive protein, and tumour necrosis factor-alpha [
45]. Moreover, HILT increases local tissue temperature and blood circulation in knee joints, promoting the exchange of nutrients in cartilage, stimulating tissue regeneration, and reducing pain, oedema, and inflammation [
4]. Consequently, these mechanisms lead to better outcomes following HILT than LLLT in relieving KOA pain [
15,
16].
Meanwhile, based on the assessments of active knee flexion range and functional mobility (TUG), the group receiving HL+EX showed a 9% increase in active knee flexion and TUG, compared to LL+EX (3% for active knee flexion and 6% for TUG). These improvements could be attributed to the established KOA rehabilitation exercises prescribed as their primary treatment, including (i) stretching exercises which are effective in increasing active joint ROM by developing greater stretch tolerance [
26,
27], and (ii) strengthening exercises for the quadriceps and hamstrings muscles, which serve as knee joint dynamic stabilizers, resulting in higher cadence and lower risk of falls [
26,
46]. Besides the prescribed rehabilitation exercises, better pain management with laser treatment can enhance physical capacity and performance [
6,
8], especially through HILT [
16]. Furthermore, in the present study, HL+EX has been demonstrated to produce a higher reduction in knee-related disability level as measured using the KOOS (reduction in KOA pain and symptoms, increase in ADL and sports participation, and improvement of QOL) compared to LL+EX. Previous research has suggested that disability in individuals with KOA results from the intricate interactions between knee pain as the primary symptom and physical function [
47,
48]. Therefore, it can be expected that reducing knee pain (as evaluated by NPRS) and increasing knee joint range of motion and functional mobility (measured through active knee flexion and TUG) would be reflected through a reduction in the level of knee-related disability [
47,
48,
49]; as indicated based on amelioration in KOA symptoms and improvement of functional activity participation as measured by the KOOS.
This double-blinded trial was conducted with a heterogeneous sample, and random group allocation was used to assign participants. The baseline comparison revealed no significant differences between the groups in terms of baseline clinical outcomes or sociodemographic factors as potential confounding variables. In addition, all participants in both groups completed their respective treatment protocols and pre-post assessments. Findings from the multi-modal assessments, including self-reported, clinician-administered, and performance-based evaluations, may provide sufficient evidence to support the integration of HILT in the management of mild to moderate KOA. However, some limitations need to be considered. First, since only pre- and post-intervention outcomes were assessed, it is not possible to evaluate long-term effects (> 4 months). Second, due to the use of self-reported measures in the evaluation of knee pain and knee-related disability, there could be a potential bias as subject perception may vary [
20]. Therefore, this study suggests that future comparative research should incorporate follow-up periods to evaluate the long-term results and objective clinical measures, such as biomarkers associated with bone or cartilage for KOA.